Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis

Article Gastroenterology & Hepatology

Targeting the gut-liver-immune axis to treat cirrhosis

Thomas Henry Tranah et al.

Summary: Cirrhotic portal hypertension is characterized by the development of serious complications such as ascites, encephalopathy, bleeding, and hepatorenal syndrome, which are often caused by cirrhosis-associated immune dysfunction. Bacterial infections are common complications of chronic liver disease and are closely linked to dysbiosis of the intestinal microbiota.

GUT (2021)

添加到收藏夹

Review Immunology

Gut microbiome, liver immunology, and liver diseases

Rui Wang et al.

Summary: The delicate interaction between the gut microbiota and liver is crucial in preventing accidental immune activation against harmless antigens, also aiding in understanding and treating various liver diseases.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Role of the Gut Microbiome in Liver Cirrhosis Treatment

Na Young Lee et al.

Summary: Liver cirrhosis is a common chronic liver disease worldwide with various causes, and there is still no clear consensus on its treatment. Recent studies have shown that modulating the gut microbiome with probiotics can ameliorate the progression of liver disease, indicating a potential new treatment approach for cirrhosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hepatitis B Virus Cure: Targets and Future Therapies

Hye Won Lee et al.

Summary: Chronic hepatitis B virus (HBV) infection is a major global health issue with progress in treatment but challenges remain. Antivirals do not directly target HBV DNA, leading to reactivation. New treatment strategies and drugs are under investigation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Gastroenterology & Hepatology